Clover Health, a provider of Medicare Advantage health plans to older Americans, posted rising revenues and a narrower loss in its most recent financial results, published in advance of a planned public market debut.
Subscribe to the Crunchbase Daily
Two weeks ago, San Francisco-based Clover announced it will go public in a $3.7 billion merger agreement with Social Capital Hedosophia III, a blank-check acquisition company led by billionaire Chamath Palihapitiya. Earlier today, the acquirer submitted the first of several securities filings laying out the financial history and post-merger plans for the combined company.
The filing shows that in the first half of this year, Clover pulled in $338 million in revenue, virtually all from premiums, and posted a net loss of $23 million. In the same period a year ago, meanwhile, Clover had lower revenue of $231 million and a higher net loss of $233 million (of which $131 million stemmed from what it described as a loss on a derivative, rather than a core expense of running its business.)
Founded in 2013, Clover describes itself as a next-generation Medicare Advantage insurer that aims to provide American seniors with affordable, high-quality health plans. Its flagship platform, the Clover Assistant, aggregates millions of relevant health data points–including claims, medical charts and diagnostics–and uses machine learning to provide essential information and personalized care recommendations to primary doctors.
As of the end of June, Clover counted 56,815 members, up from 30,677 in January 2018. Currently, over 2,100 primary care physicians who treat members have contracted to use the Clover Assistant to manage care.
As a private company, Clover raised at least $925 million in known funding, per Crunchbase data, an enormous amount for a venture-backed company. Its largest venture stakeholders include Greenoaks Capital (28 percent of voting shares) and Sequoia Capital (4 percent). Co-founder and CEO Vivek Garipalli holds 27 percent of voting shares.
Illustration: Dom Guzman
Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.